Technical Analysis for CTMX - CytomX Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Flat | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 200 DMA Support | Bullish | -2.86% | |
| Hammer Candlestick | Bullish | -2.86% | |
| Lizard Bullish | Bullish Day Trade Setup | -2.86% | |
| Narrow Range Bar | Range Contraction | -2.86% | |
| Wide Bands | Range Expansion | -2.86% | |
| Oversold Stochastic | Weakness | -2.86% | |
| 200 DMA Support | Bullish | -2.86% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 2 days ago |
| Down 1% | 2 days ago |
| 10 DMA Resistance | 2 days ago |
| Up 5% | 2 days ago |
| Up 3% | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/15/2024
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., and ImmunoGen, Inc. to develop selected Probody therapeutics. The company was founded in 2008 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Compugen Monoclonal Antibody Therapy Immunogen Oncology Focused Biopharmaceutical
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Compugen Monoclonal Antibody Therapy Immunogen Oncology Focused Biopharmaceutical
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.85 |
| 52 Week Low | 1.04 |
| Average Volume | 7,689,635 |
| 200-Day Moving Average | 1.69 |
| 50-Day Moving Average | 2.22 |
| 20-Day Moving Average | 2.35 |
| 10-Day Moving Average | 1.81 |
| Average True Range | 0.27 |
| RSI (14) | 40.12 |
| ADX | 15.23 |
| +DI | 29.65 |
| -DI | 29.59 |
| Chandelier Exit (Long, 3 ATRs) | 5.03 |
| Chandelier Exit (Short, 3 ATRs) | 2.50 |
| Upper Bollinger Bands | 4.28 |
| Lower Bollinger Band | 0.42 |
| Percent B (%b) | 0.33 |
| BandWidth | 164.03 |
| MACD Line | -0.20 |
| MACD Signal Line | -0.14 |
| MACD Histogram | -0.0678 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.91 | ||||
| Resistance 3 (R3) | 1.93 | 1.89 | 1.88 | ||
| Resistance 2 (R2) | 1.89 | 1.83 | 1.88 | 1.86 | |
| Resistance 1 (R1) | 1.79 | 1.80 | 1.77 | 1.77 | 1.85 |
| Pivot Point | 1.75 | 1.75 | 1.74 | 1.74 | 1.75 |
| Support 1 (S1) | 1.65 | 1.69 | 1.63 | 1.63 | 1.55 |
| Support 2 (S2) | 1.61 | 1.66 | 1.60 | 1.54 | |
| Support 3 (S3) | 1.51 | 1.61 | 1.53 | ||
| Support 4 (S4) | 1.49 |
